Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-articular Injection of Type I Atelocollagen to Alleviate Knee Pain: A Double-blind, Randomized Controlled Trial

NCT02539095 is registered in ClinicalTrials.gov with Cellontech Co., Ltd. as lead sponsor.

NCT NCT02539095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02539095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-articular Injection of Type I Atelocollagen to Alleviate Knee Pain: A Double-blind, Randomized Controlled Trial
Lead sponsor
Cellontech Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2014
Completion date
August 31, 2015
Enrollment
200 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chondromalacia, osteoarthritis, traumatic arthritis